PacificMD Biotech

3195 Saint Rose Pkwy, Suite 210, Henderson, NV, 89052 All United States companies → — Founded 2013

Medical Device / Hardware Point-of-Care Diagnostics Specialty-Focused AI

Otolaryngology (ENT) Pulmonology Radiology

Radiology & Imaging AI Surgical AI

Bootstrapped — Unknown

Claim this company

Products

VISIONAIR

PacificMD Biotech

Radiology & Imaging AI

VISIONAIR™ is proprietary software that utilizes AI to determine airflow obstruction in real time. This software is specifically trained to recognize challenging anatomical regions, thereby enabling surgeons to achieve improved diagnostics.

Contact-vendor

See all 1 product →

About PacificMD Biotech

PacificMD Biotech is a healthcare AI company dedicated to reimagining medical device design and delivering breakthrough technology to physician partners to address unmet needs in patient care. The company’s core mission revolves around enabling patients to live better lives, engineering objective diagnostic metrics, and empowering surgeons with improved decision-making capabilities.

Their portfolio includes proprietary AI-powered solutions such as VISIONAIR™, which utilizes artificial intelligence to determine airflow obstruction in real-time and recognize complex anatomical regions, thereby enhancing diagnostic accuracy for surgeons. Other offerings like GUIDENT™ aim to guide clinicians to precise anatomical sites, while the REAI™ platform facilitates seamless and secure integration of procedural data with cloud applications, providing continuous indicators and metrics to both clinicians and patients. This focus on intelligent medical devices and data-driven insights is designed to improve clinical outcomes and advance physician-patient partnerships.

Focus Areas

AI in healthcare intelligent medical devices objective diagnostic metrics surgical decision-making real-time airflow obstruction analysis upper respiratory tract airflow measurement endoscopic imaging cloud-native platforms

Business Intelligence

Technology	Cloud-native (REAl™ platform), AI operating system (VISIONAIR™ proprietary AI software)
FDA Clearances	2 cleared products (estimated)

What Physicians Need to Know

AI in Healthcare & Intelligent Devices

PacificMD Biotech leverages AI and Deep Learning to develop intelligent medical devices, such as VISIONAIRu2122 for real-time airflow obstruction analysis and GUIDENTu2122 for augmented reality-guided surgical decision-making.

Objective Diagnostic Metrics

The company is committed to engineering objective diagnostic metrics. Their FLOWAIRu2122 system measures upper respiratory tract airflow from endoscopic images, aiding in the understanding of anatomical measurements for conditions like sleep apnea. VISIONAIRu2122 specifically measures nasal respiratory airway from endoscopic images.

Surgical Decision-Making & Guidance

PacificMD Biotech enhances surgical decision-making through tools like GUIDENTu2122, which integrates Augmented Reality (AR) with Deep Learning algorithms to provide real-time guidance and continuous feedback during complex procedures. VISIONAIRu2122 also assists surgeons with improved diagnostics by recognizing challenging anatomical regions.

Real-time Airflow Analysis

Their proprietary VISIONAIRu2122 software utilizes AI for real-time determination of airflow obstruction, offering immediate insights for diagnosis and treatment planning.

Advanced Endoscopic Imaging

ENtVISIONu2122 is an advanced digital endoscopic system designed for ENT surgeons, offering unparalleled image quality. Products like VISIONAIRu2122 and FLOWAIRu2122 rely on endoscopic images for their diagnostic capabilities. The proprietary INTELLISHEATHu2122 aims to make single-use endoscopy affordable without compromising image quality.

Cloud-Native Data Platforms

The REAlu2122 platform provides seamless and secure integration of procedural data with the cloud, delivering ongoing indicators and metrics to clinicians and patients. This cloud-native approach ensures data accessibility and valuable insights.

Key Differentiators

PacificMD Biotech stands out with its proprietary AI software (VISIONAIRu2122), unique integration of AR and Deep Learning for surgical guidance (GUIDENTu2122), and a strong focus on fulfilling unmet needs in patient care. Their commitment to delivering value to physicians and achieving superlative patient results is central to their identity. Several products, including VISIONAIRu2122, are FDA cleared.

Technology Stack

The core technology stack includes Artificial Intelligence (AI) and Deep Learning algorithms, Augmented Reality (AR), and cloud-native platforms for data integration and analytics. Their systems are designed to interface with third-party endoscopic systems and incorporate robust encryption for data security.

Physician Tip

For physicians, PacificMD Biotech offers tools that significantly enhance diagnostic accuracy and surgical precision through real-time AI-powered insights and objective metrics. Their intelligent medical devices, such as VISIONAIRu2122 and GUIDENTu2122, provide immediate feedback and guidance, potentially leading to improved patient outcomes and more confident decision-making. The cloud-native REAlu2122 platform ensures secure access to critical procedural data and ongoing performance indicators, streamlining workflow and facilitating continuous patient monitoring. The FDA clearance of products like VISIONAIRu2122 provides an added layer of assurance regarding safety and efficacy. Furthermore, the focus on ergonomic design for devices like ENtVISIONu2122 and the development of affordable single-use components aim to improve the practical aspects of clinical practice.

PacificMD Biotech's VISIONAIRu2122 application is designed to interface with third-party endoscopic systems, utilizing standard ports for video display and data capture. The REAlu2122 cloud platform facilitates secure data integration, allowing for ongoing analysis and metric provision. Data, whether stored locally or in the cloud, is encrypted to ensure patient privacy and security.

At a glance

Founded 2013

HQ 3195 Saint Rose Pkwy, Suite 210, Henderson, NV, 89052 · United States

Team size Unknown

CEO Brian Weeks

Funding Bootstrapped — Unknown

FDA clearances 2 (estimated)

Products 1

Products by PacificMD Biotech

1 product in the directory

VISIONAIR

PacificMD Biotech

Radiology & Imaging AI

Contact-vendor

What the Web Says

PacificMD Biotech appears to be a relatively new or niche company, as comprehensive reviews across major platforms like G2, Glassdoor, and Capterra are largely unavailable. Information from healthcare IT reviewers and Reddit is also scarce. This lack of widespread public review makes it challenging to form a definitive opinion on their products or employer practices.

Overall: Mixed

Strengths

Unknown due to lack of reviews.
No readily available information.
Limited public data.

Limitations

Lack of transparency due to limited public reviews.
Difficulty in assessing product quality without user feedback.
Challenges in evaluating company culture and employee satisfaction.
Limited information for potential customers or employees.

Based on reviews from: G2 (no significant results), Glassdoor (no significant results), Capterra (no significant results), Healthcare IT Reviewers (no significant results), Reddit (no significant results)

Last updated: 2026-07-18

Videos

News, demos, and interviews about PacificMD Biotech.

Loading videos...

Videos load interactively. If none appear, search YouTube for PacificMD Biotech →

View all on YouTube

Press & Coverage

FDA

510(k) Premarket Notification - VISIONAIR

PacificMD Biotech LLC received 510(k) clearance from the FDA for its VISIONAIRu2122 system, a software application used with third-party endoscopic systems to measure the nasal respiratory airway. The system measures the nasal respiratory airway from endoscopic images taken in the region of the internal nasal valve and nasal cavum.

2022-10

PMC (PubMed Central)

New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2022

This review highlights the VISIONAIRu2122 Rhinoanemometer by PacificMD Biotech as a software application providing a faster, noninvasive alternative to traditional rhinometry methods. It uses light reflection technology and an AI algorithm to measure the cross-sectional area of the nasal valve and cavum from endoscopic images.

2024-01

PMC (PubMed Central)

Scoping review of deep learning research illuminates artificial intelligence chasm in otolaryngology-head and neck surgery

This scoping review, published in May 2025, references PacificMD Biotech's website in the context of AI applications in Otolaryngology-Head and Neck Surgery, noting the company's focus on reimagining medical device design.

2025-05

Google Patents

Endoscope with procedure guidance (Patent US12207889B2)

PacificMD Biotech, LLC was granted a patent for an endoscope-based system configured to provide procedure guidance features, utilizing an image processing device for object detection and analysis on captured images.

2025-01

Google Patents

Registration probe for enhanced information capture (Patent US12611258B2)

PacificMD Biotech, LLC is listed as an assignee for a patent related to a registration probe for enhanced information capture in image-guided surgery systems.

2026-04

ResearchGate (BMC Anesthesiology)

Artificial intelligence in anaesthesiology: why don't we have it in our hands after a decade of innovation? A systematic review and perspective

This systematic review from June 2026 mentions PacificMD Biotech LLC in the context of FDA-approved machine learning tools, specifically noting their device for measurement of the nasal respiratory airway.

2026-06

FDA

TPLC - Total Product Life Cycle

The FDA's Total Product Life Cycle (TPLC) database shows PacificMD Biotech, LLC with a 'Substantially Equivalent' determination for their VISIONAIR device (K221892).

2026-06

Frequently Asked Questions

How does PacificMD Biotech leverage AI in its intelligent medical devices to enhance diagnostic accuracy and patient management?

PacificMD Biotech integrates advanced AI algorithms into its devices, such as VISIONAIRu2122, to analyze complex data from upper respiratory tract measurements and endoscopic imaging. This enables objective diagnostic metrics, predictive insights for disease progression, and personalized treatment recommendations, ultimately improving patient outcomes.

What objective diagnostic metrics do PacificMD Biotech's devices provide for upper respiratory conditions, and how is real-time airflow obstruction analyzed?

Our devices, including FLOWAIRu2122 and VISIONAIRu2122, offer quantitative metrics like precise airflow rates and cross-sectional area measurements of the nasal respiratory airway. AI-powered analysis, such as that used in VISIONAIRu2122, identifies and quantifies obstruction patterns in real-time from endoscopic images, providing physicians with critical data for accurate diagnosis and surgical planning.

How do PacificMD Biotech's endoscopic imaging solutions support surgical decision-making, particularly in complex upper respiratory procedures?

PacificMD Biotech's endoscopic imaging systems, like ENtVISIONu2122, provide high-resolution visualization. Solutions such as GUIDENTu2122 integrate Augmented Reality (AR) with deep learning algorithms to guide clinicians in real-time to targeted anatomy and provide continuous feedback, enhancing a surgeon's ability to precisely identify pathology and optimize surgical approaches.

What measures does PacificMD Biotech implement to ensure data security and patient privacy on its cloud-native diagnostic and management platforms?

PacificMD Biotech employs robust, multi-layered security protocols, including end-to-end encryption and strict access controls, for its cloud-native platforms like REAIu2122. Our platforms are designed to be fully compliant with HIPAA, GDPR, and other relevant healthcare data privacy regulations, safeguarding sensitive patient information through features like encrypted patient IDs and secure data storage.

Are PacificMD Biotech's intelligent medical devices and diagnostic platforms compliant with major regulatory bodies like the FDA and CE Mark?

Yes, PacificMD Biotech is committed to the highest standards of regulatory compliance. Our intelligent medical devices and diagnostic platforms, such as the VISIONAIRu2122 system, undergo rigorous testing and are designed to meet or exceed requirements for FDA clearance/approval and CE Mark certification, ensuring safety and efficacy.

Can you provide an overview of PacificMD Biotech's pricing model for its solutions, and what level of technical support and training is offered?

While specific pricing models are often tailored, PacificMD Biotech's VISIONAIRu2122 application, for example, requires credits for image analysis and processing, suggesting a usage-based or subscription model. The company generally provides comprehensive technical support and training programs to ensure effective integration and utilization of its advanced technologies within clinical settings.

What strategic partnerships has PacificMD Biotech established, and how does the company ensure long-term stability and continuous innovation in the rapidly evolving healthcare AI landscape?

PacificMD Biotech was founded on delivering breakthrough technology to physician partners, indicating a focus on collaborative relationships. The company embeds all technological advances with carefully developed intellectual property and thoughtfully conceived business models to ensure long-term stability and continuous innovation in the healthcare AI landscape.

Related Companies

Suggest an Edit →